2-44275649-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000260649.11(SLC3A1):āc.114A>Cā(p.Gly38=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.767 in 1,613,626 control chromosomes in the GnomAD database, including 480,440 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.75 ( 43627 hom., cov: 33)
Exomes š: 0.77 ( 436813 hom. )
Consequence
SLC3A1
ENST00000260649.11 synonymous
ENST00000260649.11 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0880
Genes affected
SLC3A1 (HGNC:11025): (solute carrier family 3 member 1) This gene encodes a type II membrane glycoprotein which is one of the components of the renal amino acid transporter which transports neutral and basic amino acids in the renal tubule and intestinal tract. Mutations and deletions in this gene are associated with cystinuria. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 2-44275649-A-C is Benign according to our data. Variant chr2-44275649-A-C is described in ClinVar as [Benign]. Clinvar id is 336184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-44275649-A-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.088 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.817 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC3A1 | NM_000341.4 | c.114A>C | p.Gly38= | synonymous_variant | 1/10 | ENST00000260649.11 | NP_000332.2 | |
SLC3A1 | XM_011533047.4 | c.114A>C | p.Gly38= | synonymous_variant | 1/10 | XP_011531349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC3A1 | ENST00000260649.11 | c.114A>C | p.Gly38= | synonymous_variant | 1/10 | 1 | NM_000341.4 | ENSP00000260649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.752 AC: 114387AN: 152090Hom.: 43579 Cov.: 33
GnomAD3 genomes
AF:
AC:
114387
AN:
152090
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.723 AC: 181054AN: 250552Hom.: 67633 AF XY: 0.735 AC XY: 99502AN XY: 135426
GnomAD3 exomes
AF:
AC:
181054
AN:
250552
Hom.:
AF XY:
AC XY:
99502
AN XY:
135426
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.769 AC: 1123652AN: 1461418Hom.: 436813 Cov.: 61 AF XY: 0.772 AC XY: 560974AN XY: 726974
GnomAD4 exome
AF:
AC:
1123652
AN:
1461418
Hom.:
Cov.:
61
AF XY:
AC XY:
560974
AN XY:
726974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.752 AC: 114494AN: 152208Hom.: 43627 Cov.: 33 AF XY: 0.746 AC XY: 55476AN XY: 74414
GnomAD4 genome
AF:
AC:
114494
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
55476
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2236
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cystinuria Benign:4
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Benign, criteria provided, single submitter | research | Biotechnology Lab, University of Central Punjab | Feb 10, 2023 | A molecular and computational study performed on the Pakistani population reported this synonymous variant (G38=) in the SLC3A1 gene, as a benign variant, by using the technique of Next-generation sequencing. This variant might be the reason for causing the disease or increasing the severity of the already inherited Cystinuria. The variant was confirmed by ARMS-PCR at the population level (Zafar & Awais, 2023). - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 20, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at